2020 EAPCI core curriculum for percutaneous cardiovascular interventions by Van Belle, Eric et al.






























E A P C I  C O R E  C U R R I C U L U M
© Europa Digital & Publishing 2021. All rights reserved.
*Corresponding authors: Institut Cœur Poumon (Heart and Lung Institute), Bd du Pr Leclercq, CHU Lille, 59000 Lille, France. 
E-mail: ericvanbelle@aol.com
2020 EAPCI Core Curriculum for Percutaneous 
Cardiovascular Interventions
Eric Van Belle1*, MD, PhD; Rui C. Teles2, MD; Stylianos A. Pyxaras3, MD; Oliver Kalpak4, MD; 
Thomas Johnson5, BSc, MBBS, MD, FRCP; Israel Moshe Barbash6, MD; Giuseppe De Luca7, MD; 
Jorgo Kostov4, MD; Radoslaw Parma8, MD, PhD; Flavien Vincent1, MD; Salvatore Brugaletta9, MD, PhD; 
Nicolas Debry1, MD; Gabor G. Toth10, MD, PhD; Ziyad Ghazzal11, MD; Pierre Deharo12, MD; 
Dejan Milasinovic13, MD; Klaus Kaspar14, MD; Francesco Saia15, MD, PhD; Josepa Mauri16, MD; 
Jürgen Kammler17, MD; Douglas Muir18, MD; Stephen O'Connor19, MD; Julinda Mehilli20, MD; 
Holger Thiele21, MD; Daniel Weilenmann22, MD; Nils Witt23, MD; Francis Joshi24, MD; 
Rajesh Kharbanda25, MD; Zsolt Piroth26, MD; Wojciech Wojakowski8, MD; Alexander Geppert27, MD; 
Giuseppe Di Gioia28, MD; Gustavo Pires-Morais29, MD; Anna Sonia Petronio30, MD, FESC; 
Rodrigo Estévez-Loureiro31, MD; Zoltan Ruzsa32, MD, PhD; Joelle Kefer33, MD, PhD; Vijay Kunadian34, MD; 
Nicolas Van Mieghem35, MD, PhD; Stephan Windecker36, MD; Andreas Baumbach37, MD, FESC; 
Michael Haude38, MD; Dariusz Dudek39, MD, PhD; Committee for Education and Training of the European 
Association of Percutaneous Cardiovascular Interventions (EAPCI), a branch of the European Society of 
Cardiology
The authors' affiliations can be found in the Appendix paragraph.
E. Van Belle, R.C. Teles, S.A. Pyxaras, O. Kalpak, T. Johnson, I.M. Barbash, G. De Luca, J. Kostov, R. Parma, F. Vincent, S. Brugaletta, 
N. Debry, G.G. Toth, Z. Ghazzal, P. Deharo, D. Milasinovic, K. Kaspar, and F. Saia contributed equally to this manuscript.
Abstract
The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an 
updated European consensus that defines the level of experience and knowledge in the field of percu-
taneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes 
among countries, and is the cornerstone of the new EAPCI certification, designed to support the recogni-
tion of competencies at the European level and the free movement of certified specialists in the European 
Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percu-
taneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from 
previous EAPCI core curricula and from the “2013 core curriculum of the general cardiologist” to follow 
the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unani-
mous - consensus among the task force members on the training required for the interventional cardio-
logist of the future. The document recommends that acquisition of competence in interventional cardiology 
requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first 
part of the curriculum covers general aspects of training and is followed by a comprehensive description of 
the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is 












The present version of the Core Curriculum for Percutaneous 
Cardiovascular Interventions was organised and developed by 
the Education and Training Committee (ETC) of the European 
Association of Percutaneous Coronary Interventions (EAPCI), 
under the leadership of EAPCI Presidents Michael Haude and 
Andreas Baumbach.
In most countries, the prevalence of coronary artery disease 
(CAD), valvular heart disease (VHD), peripheral vascular disease 
(PVD) and heart failure (HF) is increasing. This relates both to the 
progressive ageing of the population and to a better identification 
of these diseases. To date, cardiovascular disease remains the lead-
ing cause of death worldwide. In Europe, ischaemic heart disease 
now accounts for almost 1.8 million annual deaths while VHD is 
becoming a pressing clinical issue1,2.
The main areas of the percutaneous cardiovascular interven-
tional field, as covered by the interventional cardiologist (IC), are 
percutaneous coronary interventions (PCI), transcatheter valvu-
lar interventions, percutaneous interventions for PVD (including 
those for ischaemic stroke), and percutaneous interventions for HF 
(including those for cardiogenic shock).
The broad use of these interventions is supported by overriding 
scientific evidence and has been associated with durable benefits 
for both individuals and populations3-12. In this context, ensur-
ing quality of patient care, and clinical excellence in percutane-
ous cardiovascular interventions are of the utmost importance. 
The completion of a dedicated curriculum provides the IC with 
the knowledge, skills, behaviours and attitudes to act as an expert 
in the invasive physiological and anatomic assessment, diagnosis, 
and management of coronary and structural heart diseases as well 
as in the invasive management of HF and PVD.
The first and only “Curriculum and syllabus for Interventional 
Cardiology subspecialty training in Europe” was published in 2006 
by di Mario et al on behalf of the “Working Group 10 of the ESC” 
(which later became the EAPCI) and a panel of experts in educa-
tion including the chairmen of the national interventional societies, 
coordinated by the European Board for the Specialty of Cardiology 
(EBSC)13. This document was very ambitious and addressed the need 
for a certified, uniform, training programme, before cardiologists 
engage in interventional procedures that carry a potential risk. It 
was divided into several parts: rationale and aims of the curriculum, 
structure of the training programme, assessment methods, organisa-
tion of the training and, importantly, a syllabus-specific programme 
content with several chapters (basic science, pharmacology, imag-
ing, indication for treatment and patient selection, procedural tech-
niques, management of complications of percutaneous intervention 
and miscellaneous). Some procedures were not considered to be part 
of the core curriculum but rather an “optional” part of the training.
The 2006 visionary document set the European standards although 
these were not broadly adopted. The present approach intends to 
overcome the main limitations identified in the previous document, 
namely its endorsement and promotion by the interventional and 
general cardiology societies. The proposed core curriculum aims to 
support the educational requirements and to fill the gap of an updated 
European consensus that defines the level of competences in the 
field of percutaneous cardiovascular intervention. It promotes homo-
genous education and training programmes in interventional cardio-
logy among countries, and is the cornerstone of the new EAPCI 
certification, designed to support the recognition of knowledge, skills, 
behaviours and attitudes of newly trained interventional cardiologists.
Considering the distinct realities among European and other 
countries and because numbers are not sufficient per se to describe 
the proficiency of an IC, the present document is not recommend-
ing minimal procedural volume for trainees or for training cen-
tres. It is rather providing guidance on the “achievements” and 
on the “levels of competence” which have to be acquired by the 
trainees (Table 1-Table 3). We also provide detailed information 
on how a training centre will have to be organised, including the 
Table 1. Summary of the general aspects of training in 
interventional cardiology.
Area of training General aspects of training
Continuous medical 
education
Structured learning under supervision, including explicit 
learning and implicit learning.
Supervision and 
mentoring
Acute and elective cases with direct supervision, 
progressing from second, to first and ultimately independent 
operator status.
Research Participation in clinical/translational research to enhance 
critical appraisal of evidence.
Evaluation Clearly defined for each individual, with regular review/
appraisal of their progress and formal assessment. 
Out-patient care Preprocedural and post-procedural assessment.
Acute coronary 
syndrome, STEMI 
Appropriate mix of in-patient/emergency and out-patient/
elective care, including patients with “acute coronary 
syndrome” and “out-of-hospital cardiac arrest”.
Percutaneous 
coronary interventions




Exposure to structural intervention is strongly recommended. 
Heart Team Regular participation in the Heart Team meetings.
Table 2. Description of levels translating competence into 
investigational or procedural skills (adapted from EPA).
Technique Description of competence
Level I* No performance, even with direct supervision. 
Observation is recommended
Level II* Performance as second operator and/or with direct, 
proactive supervision
Level III Performance as first operator with reactive supervision, 
i.e., on request and quickly available
Level IV Performance as first operator without supervision. 
Possibility of post hoc supervision.
Level V** Performance as first operator without supervision and 
ability to teach/supervise more junior colleagues
* Level I and II intervention skills may be acquired outside the primary 
training centre, as part of a cooperation programme. ** Level V 
intervention skills are not expected in all areas at the end of the two 
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need to involve at least two ICs with more than five years’ expe-
rience dedicated to the percutaneous cardiovascular interventional 
field (Table 4).
The EAPCI has designed a new two-part certification process: 
part A (theoretical) and part B (practical). Part A is a multiple choice 
question (MCQ) exam held twice a year, based on the present 
core curriculum, as well as the EAPCI Textbook of Interventional 
Cardiology, the ESC General Cardiology Core Curriculum and 
the content of the Fellows Course of the EAPCI. The exam was 
successfully launched at EuroPCR 2018 in Paris. Part B, which 
Table 3. Level of competence translating into interventional cardiology skills.
Technique Description of competence
Level of 
competence
Peripheral venous access Performance as first operator and teaching/supervision to more junior colleagues V
Radial access Performance as first operator and teaching/supervision to more junior colleagues V
Femoral access <10 Fr Performance as first operator and teaching/supervision to more junior colleagues V
Femoral access ≥10 Fr Performance with reactive supervision, i.e., on request and quickly available III
Closure devices <9 Fr Performance as first operator and teaching/supervision to more junior colleagues V
Closure devices ≥9 Fr Performance with reactive supervision, i.e., on request and quickly available III
Pericardiocentesis Performance as first operator without supervision IV
Right and left haemodynamic assessment Performance as first operator and teaching/supervision to more junior colleagues V
Coronary angiography Performance as first operator and teaching/supervision to more junior colleagues V
Ventricular angiography Performance as first operator and teaching/supervision to more junior colleagues V
Peripheral angiography Performance with reactive supervision, i.e., on request and quickly available III
Cerebral angiography No performance, even with direct supervision. Observation is recommended I
PCI in simple lesions Performance as first operator without supervision IV
PCI in STEMI Performance as first operator without supervision IV
PCI in NSTE-ACS Performance as first operator without supervision IV
PCI in multivessel disease Performance as first operator without supervision IV
PCI in bypass grafts Performance as first operator without supervision IV
PCI in bifurcation lesions Performance as first operator without supervision IV
PCI in LM Performance as first operator without supervision IV
PCI in CTO Performance as second operator and/or with direct, proactive supervision II
PCI with rotablator Performance as second operator and/or with direct, proactive supervision II 
Invasive physiology (FFR, iFR, RFR and others) Performance as first operator without supervision IV
OCT/OFDI Supervision at a distance and/or post hoc IV
IVUS Supervision at a distance and/or post hoc IV
Endomyocardial biopsy No performance, even with direct supervision. Observation is recommended I
Use of percutaneous mechanical haemodynamic support Performance with reactive supervision, i.e., on request and quickly available III
Balloon aortic valvuloplasty Performance as second operator and/or with direct, proactive supervision II
TAVI Performance as second operator and/or with direct, proactive supervision II
Balloon mitral valvuloplasty Performance as second operator and/or with direct, proactive supervision II
Transcatheter mitral valve repair No performance, even with direct supervision. Observation is recommended I
Transcatheter mitral valve implantation No performance, even with direct supervision. Observation is recommended I
Transcoronary ablation of septal hypertrophy No performance, even with direct supervision. Observation is recommended I
Transcatheter pulmonary valve interventions No performance, even with direct supervision. Observation is recommended I
Left atrial appendage occlusion Performance as second operator and/or with direct, proactive supervision II 
Atrial septal defect closure or patent foramen ovale closure Performance as second operator and/or with direct, proactive supervision II 
Closure of ventricular septal defect No performance, even with direct supervision. Observation is recommended I
Percutaneous treatment of paravalvular leaks No performance, even with direct supervision. Observation is recommended I
Transcatheter myocardial stem cell therapy No performance, even with direct supervision. Observation is recommended I
Cardiac catheterisation in “grown-up congenital heart” patients Performance as second operator and/or with direct, proactive supervision II
Supra-aortic interventions including acute ischaemic stroke treatment No performance, even with direct supervision. Observation is recommended I
Aortic disease interventions (thoracic endovascular repair of aorta/
endovascular repair of aortic aneurysm) No performance, even with direct supervision. Observation is recommended I
Infra-aortic arterial disease interventions No performance, even with direct supervision. Observation is recommended I
Renovascular interventions for arterial hypertension No performance, even with direct supervision. Observation is recommended I
Transseptal puncture Performance as second operator and/or with direct, proactive supervision II 
Interpretation of multislice CT for TAVI Performance as second operator and/or with direct, proactive supervision II
Interpretation of transoesophageal echocardiography for mitral procedure Performance as second operator and/or with direct, proactive supervision II
Percutaneous direct treatment for acute pulmonary embolism No performance, even with direct supervision. Observation is recommended I
Balloon pulmonary angioplasty for “chronic thromboembolic pulmonary 









is currently under final development, is based on the recognition 
of acquisition of the competencies listed in Table 4 of the pre-
sent document. To prevent duplication, and simplify the process, 
it will preferably be conducted through a very strong interaction 
with national certification programmes when such programmes 
exist (i.e., mutual recognition process) and/or a direct interaction 
with training centres. The model of the present EAPCI certifica-
tion, in which full certification requires acquiring the two parts, is 
very similar to those developed by the other subspecialty associa-
tions of the European Society of Cardiology (ESC).
The EAPCI ETC Committee launched the project under the 
auspices of Professors Michael Haude and Andreas Baumbach. 
A total of 10 groups, consisting of two to three interventional 
cardiologists each, developed, circulated and improved the docu-
ment under the direction of the successive Chair and Co-Chair of 
the ETC, Professors Dariusz Dudek and Eric Van Belle and Doctor 
Rui Campante Teles. The document was revised by the Chair and 
Co-Chair of the ETC, Professor Eric Van Belle and Doctor Rui 
Campante Teles, as well as the current EAPCI President, Professor 
Andreas Baumbach, and President Elect, Professor Dariusz Dudek.
The 2020 Core Curriculum underwent a thorough review process 
based on the template of the review of the ESC guidelines and of 
the EAPCI textbook on percutaneous interventional cardiovascular 
medicine. The document does not include minimum or optimal num-
bers of procedures to be undertaken, and does not address periodic 
evaluation or revalidation. It defines the clinical, patient-oriented, 
training of the IC. The structure of the current core curriculum has 
been drastically modified as compared to the previous version and 
has evolved from the “2013 Core Curriculum of the general cardio-
logist” to follow the current ESC recommendations for core curri-
culums. In most subject areas, there was a wide if not unanimous 
consensus among the task force members on the training required for 
the IC of the future. The document recommends that acquisition of 
competence requires at least two years of training in interventional 
cardiology, in addition to four years devoted to cardiology.
The first part of the curriculum covers general aspects of train-
ing and is followed by a comprehensive description of the specific 
components in 54 chapters. Each of the chapters includes state-
ments of the objectives, and is further subdivided into the required 
knowledge, skills, behaviours, and attitudes.
The core curriculum for the interventional 
cardiologist
THE CLINICAL FIELD OF INTERVENTIONAL CARDIOLOGY
The clinical specialty of interventional cardiology aims to deliver 
expert interventional care for patients presenting with disorders of 
the heart, the systemic, and the pulmonary circulations. This core 
curriculum provides the standards for training in interventional 
cardiology, as well as a template for the maintenance of compe-
tence for qualified cardiologists.
The IC is the subspecialist who performs percutaneous inter-
ventional cardiovascular procedures. He/she is primarily a medi-
cal specialist with a thorough basic training in internal medicine 
who has completed an approved cardiology fellowship pro-
gramme incorporating the knowledge demanded by the ESC Core 
Curriculum for the general cardiologist14. Interventional cardio-
logists perform general cardiac investigation and management of 
patients with suspected or established cardiovascular disease using 
non-invasive methods and are involved in the comprehensive man-
agement of the patient and treatment of the underlying disease, not 
only focused on procedural considerations. They have the ability 
to consider and apply interventional techniques to the global care 
of patients. They are team workers who interact closely with other 
cardiologists and other medical specialties, nurses, paramedics and 
other healthcare professionals.
In order to master the invasive techniques, there are skills in 
several general fields which are important for the IC and require 
special differentiation that complement basic general cardiology 
skills. It is recommended that an operator be able to interpret the 
most advanced cardiology imaging techniques required for peripro-
cedural assessment, especially echocardiography, computed tomo-
graphy and endovascular studies. A high level of cardiac intensive 
care experience is requested, with a special emphasis on acute 
heart failure and arrhythmia management14.
As simulators have shown benefit in the progress of novice 
operators, they are progressively being incorporated into training 
programmes and courses15,16. While the exact role of these simu-
lators in most advanced technical skills still needs to be clarified, 
with their progressive sophistication their use in the training of 
ICs will continue to increase.




–  Number of trainees should not exceed number of trainers
–  Catheterisation laboratory conferences, at least monthly
–  Regular electronic database, audited by the national 
interventional association/working group
–  Research programme 
–  Performance measures at least annually
–  Quality programme 
–  Radiation safety programme
–  Compliance with local standards according to national 
regulation bodies, including minimal procedural volumes
Standard 
centre
–  PCI including complex procedures (mandatory)
–  Intracoronary imaging (IVUS and/or OCT, others) and invasive 
physiological assessment (FFR, iFR, RFR and others) (mandatory)
–  CTO programme (recommended)
–  Rotational atherectomy (recommended)
–  Percutaneous mechanical circulatory support devices 
(encouraged)
–  TAVI (encouraged)
Advanced 
centre 
–  PCI including complex procedures (mandatory)
–  Intracoronary imaging (IVUS and/or OCT, others) and invasive 
physiological assessment (FFR, iFR, RFR and others) (mandatory)
–  CTO programme (mandatory)
–  Rotational atherectomy and lithotripsy (mandatory)
–  Percutaneous mechanical circulatory support device programme 
(recommended)
–  TAVI (mandatory)
–  Transseptal procedures (mandatory) 
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A key role of the IC is to perform emergency procedures for 
reperfusion of acute myocardial infarction in 24/7 PCI-capable 
centres. Regarding PCI, any operator is expected to be fully com-
petent regarding the entire spectrum of patient evaluation, informa-
tion, techniques and follow-up, including all advanced techniques 
such as imaging, physiology, adverse clinical presentations and 
anatomies and adverse lesion scenarios, incorporating calcifica-
tion, degenerated grafts, simple chronic total occlusions (CTOs) 
and bifurcations in general. An IC is expected to be fully skilled 
in the management of any procedural complications.
Concerning the increasing importance of transcatheter aortic 
valve implantation (TAVI), any operator should be prepared to 
conduct complete preprocedural evaluation of TAVI candidates and 
collaborate with a valvular Heart Team to select the most suitable 
treatment.
Concomitantly, these fields are continuously expanding and, 
in certain cases, a very specific training to master a procedure or 
technique is required. Help from a proctor is recognised as advan-
tageous or an appropriate referral to a more skilled centre might be 
advisable, especially in certain areas that, depending on the indi-
vidual and the centre, require a particular expertise, namely com-
plex coronary interventions, stroke, PVD, grown-up congenital 
heart (GUCH) disease, mitral or tricuspid valve disease, left atrial 
appendage occlusion (LAAO), etc.
The spectrum of expertise is broad and, in addition to the pro-
cedures, includes a comprehensive patient risk assessment that is 
fundamental for patient information and integrates medical deci-
sion making. A multidisciplinary management strategy is essential 
including a heart failure specialist, imaging specialist, surgeons, 
geriatrician, anaesthetist and cardiac rhythm specialists17.
Because these interventions are applied to a very large popu-
lation of patients, their economic impact has become significant. 
The IC must be conscious of this economic burden and respons-
ible for the appropriate utilisation of devices and therapies.
The process for medical decision making and patient informa-
tion is guided by the “four principles” approach to healthcare eth-
ics - autonomy, beneficence, non-maleficence and justice. The 
IC represents the patient’s best interest and therefore the medical 
decision process must be independent and be performed according 
to the best available evidence, in order to deliver optimal patient-
centred care. Moreover, because this is a very technological and 
continuously demanding evolving medical area, it requires life-
long learning and continuous updating of his/her knowledge. The 
IC is expected to be engaged in structured clinical investigation 
programmes and to collaborate actively in patient follow-up.
GENERAL ASPECTS OF TRAINING IN THE SPECIALTY
Candidates for interventional training should be physicians 
licensed to practise in the country of training. The trainee must 
have the necessary linguistic ability to communicate with patients 
and colleagues in the country of training and later in the country 
of practice. The trainee should have completed a minimum of four 
years of full-time training in general cardiology.
The recommended minimum duration of dedicated subspecial-
ity training should be two years of full-time and exclusive training 
in interventional cardiology.
To gain sufficient experience, the trainee should gain exposure 
to all aspects of interventional cardiology, with an appropriate mix 
of in-patient/out-patient and emergency/elective care, including 
the elements described below and summarised in Table 1:
–  Participation in the clinical management of in-patients, with an 
emphasis on patients presenting acutely to the coronary care unit 
(CCU) and acute medical unit (AMU) with acute coronary syn-
dromes (ACS).
–  Regular on-call commitment providing a primary PCI service 
for patients presenting with ST-elevation myocardial infarction 
(STEMI) and/or out-of-hospital cardiac arrest (OHCA).
–  Regular attendance and/or coordination of Heart Team meetings.
–  Bedside patient care, including preprocedural and post-proce-
dural assessment.
–  Structured learning, under the direct supervision of educational 
supervisors/nominated trainers, which may include (a minimum 
of two hours/day is suggested):
–  explicit learning: journal club, postgraduate teaching, exer-
cises in evidence-based medicine, discussion of guidelines 
for clinical practice, national/international symposia/con-
gress attendance.
–  implicit learning: ward rounds, case-based discussions, 
supervised acquisition of diagnostic and interventional skills.
–  Interventional training should include a mix of acute and elec-
tive cases with direct supervision, progressing from second, to 
first and ultimately independent operator status by the end of the 
training period.
–  Interventional training should guarantee experience with arte-
rial access (femoral and radial), and with the most frequent of 
the complex techniques, including bifurcation strategies, treat-
ment of calcified vessels, intravascular imaging, and functional 
assessment of coronary stenoses (FFR, iFR, etc.).
–  Exposure to chronic total occlusion (CTO) strategies, with both 
antegrade and retrograde approach, atherectomy techniques 
including rotablation, haemodynamic support/mechanical circu-
latory support, is required.
–  Exposure to structural intervention including TAVI, mitral and 
tricuspid valve treatment, atrial septal defect/patent foramen 
ovale/left atrial appendage closure, and paravalvular leak/ventri-
cular septal defect closure is strongly recommended.
–  The training programme should be clearly defined for each indi-
vidual, with regular review/appraisal of their progress and formal 
assessment of their knowledge and procedural competencies.
–  Participation in clinical/translational research in interventional 
cardiology is recommended to enhance critical appraisal of 
evidence.
Learning objectives should be clearly defined and are preferred 
to recommendations based solely on the time spent in a particular 
department or on the number of procedures performed. The objec-









including communication and appropriate behaviours, competen-
cies and attitudes that will be further reinforced during ongoing 
training.
LEARNING OBJECTIVES
These are specific aims which demonstrate skills acquired by the 
trainee at the end of the course. They are based on the trainee’s 
capabilities in certain tasks. Specific objectives are classified 
according to knowledge, skills, and behaviours and attitudes.
–  Knowledge: describes requirements for trainees. The subject 
matter is defined by the EAPCI Core Curriculum chapters. This 
knowledge includes pathology of diseases as the rational basis 
for long-term learning.
–  Skills: a practical application of knowledge acquired from expe-
rience and training to solve practical problems, make clinical 
decisions and perform specific procedures.
–  Behaviours and attitudes: refer to those attitudes and behaviours 
that lead to optimal clinical performance.
CATEGORIES AND LEVELS OF COMPETENCE
First-hand exposure and practical experience are crucial in the 
learning of techniques. However, the number of procedures per-
formed by trainees is not considered an exclusive measure of per-
formance. The authors acknowledge the variability of the learning 
curve among individuals and the impact of the training centre 
volumes on the learning process. Thus, this document focuses on 
the acquisition of competencies rather than on procedural volume.
This section describes the levels to translate competencies 
into investigational or procedural skills. Their ascending order is 
defined as follows and summarised in Table 2. It has been adapted 
from the description of Entrustable Professional Activities (EPA)18:
–  Levels I and II. The trainee must have acquired experience in 
selecting an appropriate diagnosis or therapy and in interpreting 
results or choosing an appropriate treatment for a referred patient.
–  Level I does not require any procedural skills, yet participa-
tion in related procedures during training may be valuable.
– Level II of competency indicates acquisition of some proce-
dural skills as operator, usually as assistant/second operator, 
obtained in the primary or external training centres.
–  Level III. The trainee must be able to interpret clinical data, 
recognise treatment indications, and perform the technique or 
procedure and manage related complications, as first operator, 
but still requires to work under the direct supervision of a senior 
IC operator.
–  Level IV. The trainee must be independent in the ability to 
interpret clinical data, recognise treatment indications, per-
form the technique or procedure and manage related complica-
tions, as first operator without the direct supervision of a senior 
IC operator. Post hoc supervision including case review with 
more senior colleagues is possible.
–  Level V. Same as level IV. In addition, it includes the ability to 
teach and supervise the technique or procedure to more junior 
colleagues.
Table 3 summarises the level of competence translating into 
interventional cardiology skills that the EAPCI considers desir-
able for a trainee in interventional cardiology to achieve at the 
end of his/her two years of training19-24. Although organisation 
of cardiac services and resources for training are not uniform 
across Europe and ESC member countries, the core curricu-
lum aspires to an optimal, rather than a minimal standard. In 
countries or centres that are currently unable to deliver training 
in all aspects required, the core curriculum should be used as 
a benchmark to promote policies for improvement. Also, rota-
tion of trainees between different centres may provide an ade-
quate solution.
REQUIREMENTS FOR TRAINING INSTITUTIONS AND 
TRAINERS
REQUIREMENTS FOR TRAINING INSTITUTIONS
General aspects
We believe that training institution profile and performance are 
as important as trainers’ profile and expertise in order to provide 
objective and quality interventional training. In order to comply 
with EAPCI standards, the institutions must be standardised using 
procedural volume reports and performance measures.
A training institution/centre for interventional cardiology should 
include a cardiac catheterisation laboratory with on-call 24-hour 
PCI availability and a dedicated cardiology unit, department or 
ward, in order to manage patients throughout hospitalisation. The 
trainee should be able to be educated to manage patients from their 
admission, through the invasive procedure, to discharge from the 
ward. Institutional workflow allowing the interventional cardio-
logy programme attendees to follow the patient throughout their 
hospitalisation is mandatory.
The training centre should have an independent interventional 
cardiology unit, allowing the trainee to follow the patient from 
the beginning to the completion of interventional treatment. Units 
not integrated into a cardiology department (run as a service with-
out dedicated beds) can exceptionally be considered if they dem-
onstrate a well-developed structured co-operation with cardiology 
wards where the patients are admitted, allowing the interventional 
cardiology programme attendees to follow the patient throughout 
their hospitalisation.
Training centres should be encouraged to incorporate on-site 
interventional cardiology simulators or to provide simulation ses-
sions during the IC training, especially during the early phases of 
training of the trainee and/or the techniques15,16.
Training centres should have the following basic characteristics 
(summarised in Table 4):
1)  Active clinical research programme and/or involvement in 
clinical trials is mandatory for both types of centre.
2)  Number of trainees per institution should not exceed the num-
ber of faculty members/trainers.
3)  Heart Team meetings, including participation by clinical cardio-
logists, interventional operators, and cardiothoracic surgeons 
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4)  Regular database - electronic database of diagnostic and inter-
ventional procedures regularly audited by the national interven-
tional society is recommended to ensure centre quality.
5)  Performance measures report of the institution (periodic, at 
least annual): in-hospital mortality in acute, elective PCI and 
diagnostic catheterisation.
6)  Regular “quality assessment and quality improvement” (QA/
QI) programme including radiation safety programme.
We further define two types of training centre: standard and 
advanced training centre (Table 4).
–  Standard centre: must have a (mandatory) programme of 24 
hours a day availability of PCI on call for STEMI/NSTEMI 
patients and a working hours regular programme for all kinds 
of patients. Availability of IVUS and/or OCT and assessment of 
intracoronary pressure-based physiology indices such as FFR/
iFR is mandatory. It is strongly recommended that these centres 
are involved in complex PCI, including left main and multives-
sel disease. Availability of left ventricular assist devices such as 
IABP/Impella® (Abiomed, Danvers, MA, USA) is desirable but 
not mandatory as well as a CTO programme, rotational atherec-
tomy and similar procedures. Institutional coronary and struc-
tural Heart Teams are also encouraged, even if the centre does 
not perform TAVI.
–  Advanced centres: these have similar requirements to standard 
centres and should have a structural heart programme includ-
ing at least TAVI according to national regulation, transseptal 
procedures and a structured CTO programme. Other structural 
procedures (stroke, carotid, peripheral, GUCH, septal ablation, 
left atrial appendage occlusion, paravalvular leak closure, etc.) 
are recommended. The presence of a Heart Team is mandatory.
–  A centre may develop other programmes for peripheral interven-
tions (stroke, carotid stenting, aorta, peripheral limb), treatment 
of adult congenital heart disease, performance of septal ablation 
for hypertrophic cardiomyopathy, etc.
Procedural volumes and public metric reporting
It has been established that the procedural volumes of centres 
have a significant impact on the availability of training opportuni-
ties and on performance measures and intervention outcomes, but 
numbers are insufficient to define the quality of a centre and their 
ability to train interventional fellows. Public reporting of centre 
training programmes, procedural volumes and clinical outcomes 
is advisable to guide trainee choice of the training centre. While 
the present document does not make recommendations on specific 
procedural volumes, training centres should comply with local 
standards according to national regulation bodies, including mini-
mal procedural volumes.
REQUIREMENTS FOR TRAINERS
General aspects and levels of competence
Trainers should be graded as trainers in standard institutions 
(standard trainers) and trainers in advanced institutions (advanced 
trainers). Trainers should be experts for levels of competence III, 
IV and V (Table 2, Table 3). It is not required that every trainer 
be expert in those techniques for which a level of competence I 
or II (Table 2, Table 3) is required, provided trainees can rotate 
to train with an IC (in the same or different institution) with the 
necessary expertise.
Ideally, the number of trainers (full-time equivalent) should 
match or exceed the number of trainees. Delivery of the curricu-
lum may be facilitated by a structure that includes a director of 
training (national/regional), a cath lab director (or supervisor), 
a training mentor (or educational mentor), and multiple clinical 
trainers (or clinical mentors).
The training mentor (or someone else involved in the organi-
sation of training) should be responsible for organising the train-
ing programme in interventional cardiology, coordinating external 
rotations to referral centres, attendance at courses and congresses, 
and organising structured learning. It is necessary that both trainee 
and training mentors be subject to periodic assessment.
Number of trainers and their expertise
At least two trainers (supervisors) must be available, with more 
than five years’ experience dedicated to interventional cardiology 
as their main clinical activity. These trainers should be members 
of the permanent staff and should be able to deliver the procedural 
skills associated with levels of competence III, IV and V in the 
learning objectives (Table 2, Table 3).
In advanced centres, trainers should have experience of more 
than five years performing advanced heart interventions.
Trainers without personal expertise in these additional skills 
described in the learning objective (levels of competence I and II, 
Table 2, Table 3) should make them available to trainees through 
a cooperation programme with other trainers (or other institutions) 
who will deliver the formal training on these techniques. A simi-
lar five years of experience is required for the trainers delivering 
training on each one of those additional procedural skills.
The cath lab director must be responsible for the interventional 
unit and should ensure that the trainee fulfils his/her learning 
objectives. The training mentor must also ensure that the trainee 
attends the formal training courses and is involved in the research 
and educational activities of the department.
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